Cargando…

Differences in treatment patterns among patients with castration-resistant prostate cancer treated by oncologists versus urologists in a US managed care population

OBJECTIVE: Differences in treatment patterns, health care resource utilization, and costs between patients with castration-resistant prostate cancer (CRPC) treated by oncologists and those treated by urologists were examined. METHODS: Patients aged ≥40 with CRPC were identified using claims from a l...

Descripción completa

Detalles Bibliográficos
Autores principales:	Engel-Nitz, Nicole M, Alemayehu, Berhanu, Parry, David, Nathan, Faith
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2011
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3139484/ https://www.ncbi.nlm.nih.gov/pubmed/21792332 http://dx.doi.org/10.2147/CMR.S21033

Ejemplares similares

A role for pediatric oncologists/urologists?!
por: Stein, Raimund
Publicado: (2013)

Every urologist and oncologist should know about treating sexual and gender minority prostate cancer patients: translating research findings into clinical practice
por: Rosser, B. R. Simon, et al.
Publicado: (2021)

A Comparison Between the Rates of Radiation Oncologist and Urologist Consultations in Men Diagnosed With Prostate Cancer in Northern Ontario, Canada
por: Santi, Stacey A., et al.
Publicado: (2022)

Pharmacist-Urologist Collaborative Management Improves Clinical Outcomes in Patients With Castration-Resistant Prostate Cancer Receiving Enzalutamide
por: Hirabatake, Masaki, et al.
Publicado: (2022)

Radiotherapy after Radical Prostatectomy: Treatment Recommendations Differ between Urologists and Radiation Oncologists
por: Lavallée, Luke T., et al.
Publicado: (2013)

Management of Prostate Cancer During COVID-19 Pandemic: Perspective From Urologists and Radiation Oncologists in COVID Dense Metro Detroit
por: Domenig, Peter, et al.
Publicado: (2020)

New Therapeutics to Treat Castrate-Resistant Prostate Cancer
por: Acar, Ömer, et al.
Publicado: (2013)

Prostate MRI – an update for the referring urologist
por: Czarniecki, Marcin, et al.
Publicado: (2016)

Active surveillance of prostate cancer: a questionnaire survey of urologists, clinical oncologists and urology nurse specialists across three cancer networks in the United Kingdom
por: Philippou, Yiannis, et al.
Publicado: (2015)

“We talk it over” - mixed-method study of interdisciplinary collaborations in private practice among urologists and oncologists in Germany
por: Beermann, Sandra, et al.
Publicado: (2014)

Treatment Patterns of Real-World Patients with TRK Fusion Cancer Treated by US Community Oncologists
por: Klink, Andrew J, et al.
Publicado: (2022)

Challenges to treat hypogonadism in prostate cancer patients: implications for endocrinologists, urologists and radiotherapists
por: Gravina, Giovanni L., et al.
Publicado: (2015)

Practice Patterns of Korean Urologists for Screening and Managing Prostate Cancer according to PSA Level
por: Chung, Mun Su, et al.
Publicado: (2012)

Novel Strategies for Treating Castration-Resistant Prostate Cancer
por: Leung, David Ka-Wai, et al.
Publicado: (2021)

Can expressed prostatic secretions affect prostate biopsy decision of urologist?
por: Ergün, Osman, et al.
Publicado: (2019)

Pain in castration-resistant prostate cancer with bone metastases: a qualitative study
por: Gater, Adam, et al.
Publicado: (2011)

Impact of MRI/US fusion‐guided prostate biopsy on biopsy‐naïve patients: A single urologist’s experience
por: Altok, Muammer, et al.
Publicado: (2021)

Urosepsis and the urologist!
por: Ryan, James, et al.
Publicado: (2021)

Treatment patterns and survival in metastatic castration‐sensitive prostate cancer in the US Veterans Health Administration
por: Freedland, Stephen J., et al.
Publicado: (2021)

Prostate MRI: a national survey of Urologist’s attitudes and perceptions
por: Manley, Brandon J., et al.
Publicado: (2016)

Patient Preferences and Urologist Judgments on Prostate Cancer Therapy in Japan
por: Nakayama, Masahiko, et al.
Publicado: (2018)

Impact of COVID-19 on Prostate Cancer Management: Guidelines for Urologists
por: Dovey, Zachary, et al.
Publicado: (2020)

Acceptance of female urologists among patients with suspected prostate disease
por: Steinkohl, Fabian, et al.
Publicado: (2021)

The Practice of Scottish Urologists in the Assessment and Management of Fracture Risk in the Ageing Male being Treated for Prostate Cancer
por: Ngu, Wee Sing, et al.
Publicado: (2007)

Korean Urologist's View of Practice Patterns in Diagnosis and Management of Benign Prostatic Hyperplasia: A Nationwide Survey
por: Oh, Cheol Young, et al.
Publicado: (2010)

Chinese Urologists' Views of Practice Patterns in the Diagnosis and Treatment of Benign Prostatic Hyperplasia: A Nationwide Survey
por: Wu, Nan, et al.
Publicado: (2012)

US Food and Drug Administration Warning Regarding Finasteride and Suicidal Ideation: What Should Urologists Know?
por: Al Saffar, Haidar, et al.
Publicado: (2023)

Pathology Update for Urologists
por: Iczkowski, Kenneth A., et al.
Publicado: (2011)

Geographic Analysis of Urologist Density and Prostate Cancer Mortality in the United States
por: Yao, Nengliang, et al.
Publicado: (2015)

Adherence of Indonesian urologists to practice guidelines for the management of benign prostatic hyperplasia
por: Rahman, Fakhri, et al.
Publicado: (2019)

Variability in accuracy of prostate cancer segmentation among radiologists, urologists, and scientists
por: Chen, Michael Y., et al.
Publicado: (2020)

The urologist’s learning curve of “in-bore” magnetic resonance-guided prostate biopsy
por: Rosenzweig, Barak, et al.
Publicado: (2021)

Comparison of Ketoconazole and Estramustine for Treating Patients with Castration-Resistant Prostate Cancer
por: Yun, Bu Hyeon, et al.
Publicado: (2011)

Pembrolizumab in men with heavily treated metastatic castrate‐resistant prostate cancer
por: Tucker, Matthew D., et al.
Publicado: (2019)

Comprehension and Practice Patterns of Korean Urologists for Retractile and Gliding Testes
por: Kim, Jae Yeon, et al.
Publicado: (2022)

Real-World Treatment Patterns and Overall Survival of Patients with Metastatic Castration-Resistant Prostate Cancer in the US Prior to PARP Inhibitors
por: Shore, Neal D., et al.
Publicado: (2021)

Treatment patterns and characteristics of European patients with castration-resistant prostate cancer
por: Sternberg, Cora N, et al.
Publicado: (2013)

Do I need to see a urologist for my vasectomy? A comparison of practice patterns between urologists and family medicine physicians
por: Posielski, Natasza M, et al.
Publicado: (2019)

Biosimilars 101: considerations for U.S. oncologists in clinical practice
por: Camacho, Luis H, et al.
Publicado: (2014)

Pitfalls of FDG-PET in the prostate for the surgical oncologist
por: O'Connor, Ellen, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_2u4grdov3ckml10n8kp9dvuftt